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Abstract 
Multiple sclerosis is one of the chronic diseases of the central nervous system. This disease 
appears more among young adults and women. Multiple sclerosis (MS) is regarded as a 
multifactorial disease. One principal and significant probability is that viruses may stimulate the 
immune system and lead to the occurrence of MS in the persons who are susceptible to the disease. 
The purpose of the execution of this study is to detect varicella zoster virus (VZV) in the patients 
afflicted with multiple sclerosis and its comparison with a control group. Blood samples from 83 
MS patients and 100 healthy individuals were collected from Northern areas of Iran. DNA 
extraction was executed from blood by the kit and according to the instruction of the company. In 
order to make sure of the accuracy of the extracted DNA, the amplification of human beta-globin 
gene was used. Specific primers produced by TAG Copenhagen (Denmark) were used to amplify 
the viruses’ gene. At the end, chi-square(x2) statistical test was used to study the frequency of these 
viruses in the samples of MS patients and the control group and their relationship with each other. 
The findings of this study showed that 21 individuals (25%) of patients with MS and 9 individuals 
(9%) of the control group were positive to VZV virus. Statistical analysis represents a significant 
relationship between frequency of VZV and MS. The role of viral infections including VZV in the 
affliction with MS has been confirmed for about a decade. A number of studies have been succeeded 
in identification of genome of this virus in MS patients, but still more researches are required to 
perceive the relationship between viral infections and MS disease. 
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Introduction   
Multiple sclerosis (MS) is a chronic, progressive degenerative disease of the central nervous 
system in the brain and spinal cord characterized by the occurrence of small Demyelination. 
Demyelination means the destruction of myelin. Myelin is a substance made up of fat and protein 
surrounding the nerve fibers in the brain and spinal cord. Demyelination impairs the transmission of 
nerve impulse (Sholtis, 2000). MS is One of the most common neurological diseases in human 
beings and the most disabling disease in adults (Halland and Halper, 2005), and it has different 
symptoms such as vision loss, numbness and paralysis, spastic ataxia, tremor, disturbance of 
sphincter control, impotence, crippling, speech impairment, and depression (Nedjast et al., 2006). 
MS usually begins during adolescence between the ages of 20 to 35 years and is almost twice as 
common in women as in men (Soltanzadeh, 2004). Nearly 400,000 people in America and 2/2 
million people in the world develop MS (Parsa and Sadat Hosseini, 2011). It has been estimated that 
the prevalence of MS in Europe was 83 per 100 thousand in the past three decades and the annual 
incidence of the disease on the continent was 3/4 per 100 thousand (Pugliatti et al., 2006). In Iran, 
nearly 40,000 people are infected (Parsa and Sadat Hosseini, 2011). MS is a pathologically 
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autoimmune disease (Parsa and Sadat Hosseini., 2011). A series of factors involving MS has been 
identified and any of these factors may play a role in causing the disease. These factors include 
genetics, family history, environmental factors, Latitude, socioeconomic status-Migration and 
infections. Chlamydia pneumoniae, Rickettsia and Borrelia are bacterial infections, and viral 
infections are EBV, VZV, CMV, HSV, HHV-6, KSHV, CDV, and HERV. (Contini et al., 2008; 
Fainardi et al., 2008; Djelilovic and Alajbegovic, 2012; Sanadgol et al., 2011). One of the viruses 
involving MS is human herpes viruses. Herpes virus family includes some of the most important 
human pathogenic viruses. The remarkable feature of herpes virus is the ability of causing stable 
infection in the host and reactivation period, and this feature has made them considerable (Jawets, 
2001).  
VZV, as a member of Alpha-herpes virinae subfamily, causes two different diseases. This 
virus has the ability of causing the hidden infection by quick growth and cytolytic effect in neurons. 
It causes chickenpox upon primary infection, which is a very contagious disease and is common 
among children (Grant et al., 1993). Reactivation of latent virus in ganglion cells causes shingles, 
which is more common among adults. In addition to these diseases, VZV can cause respiratory, 
neurological, and skin defects in people with immunodeficiency and even those with healthy 
immune system (John and Gnann, 2002).Amplification of a small fragment of VZV genome by PCR 
is the most common technique to detect this virus in clinical samples (Druce et al., 2002). 
This study intends to investigate the prevalence of VZV virus in blood samples from MS 
patients. In case of a significant prevalence of the virus in these patients compared with the control 
group, the results of this study may help to stabilize assumptions related to infectious diseases and 
MS, so this study was designed and implemented. 
 
Materials and Methods 
Sample collection 
In this study, 183 blood samples were collected from different regions in the northern areas 
of Iran, and then were transferred to Genetics Research Laboratory at the University in Tonekabon 
Branch. Blood samples belong to 83 patients (24 males, 59 females), and 100 blood samples were 
collected from the control group matched the patient group by age and gender. It should be noted 
that diagnostic of the disease was done by a neurologist and MRI test, and all the patients in this 
study were in Relapsing Remitting Multiple Sclerosis (MSRR). The collected blood samples 
transported in the tubes containing EDTA anticoagulant and they were maintained at the -20°С until 
the start of the experiment. 
DNA extraction 
1. Qiagene, Lot No:k92-8 , Cat No:k1014-100). The purity of the extracted DNA was 
analyzed based on absorbance of the extracted DNA at 230 and 260 nm wavelengths by 
biophotometer (Eppendorf- Germany). 
Human beta-globin gene amplification 
Amplification of human beta-globin gene was used in order to make sure of accuracy of the 
extracted DNA by using the following primers: betaglobin-f:5'-TCCAACATCAACATCTTGG T-3' 
and betaglobin-R:5’-TCCCCCAAATTCTAAGCAGA-3' that produced by TAG Copenhagen 
(Denmark) (Zaravinos et al., 2009). Each reaction was performed in a total volume of 20 μl, which 
contained 10 μl of primer taq premix(2X), 1 μl of 10 pmol of forward and reverse PCR primers, 3 μl 
of Distilled water and 5 μl of DNA template. PCR amplification conditions on thermocycler 
(Biorad-Germany) were as follows: 95°C for 5 min, followed by 35 cycles of 95°C for 45 S, 54°C 
for 30 S and 72°C for 30 S, with a final extension at 72°C for 5 min. An aliquot of all PCR products 
was run on a 1.5% (w/v) agarose gels with a 100 bp DNA ladder. 
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Polymerase chain reaction for the detection of varicella zoster virus 
Specific Primers produced by TAG Copenhagen (Denmark) were used to amplify the VZV 
gene. The sequences of forward and reverse primers were 5'- ATGTCCGTACAACATCAACT -3' 
and 5'-CGATTTTCCAAGAGAGACGC -3'(Zaravinos et al., 2009). Each reaction was performed in 
a total volume of 20 μl, which contained 10 μl of primer taq premix(2X), 1 μl of 10 pmol of forward 
and reverse PCR primers, 3 μl of Distilled water and 5 μl of DNA template. The negative control 
tube contained the same PCR reagents as mentioned above but had 5 μl of water substituted for the 
DNA template. PCR amplification conditions on thermocycler (Biorad-Germany) were as follows: 
95°C for 5 min, followed by 40 cycles of 94°C for 45 S, 54.5°C for 40 S and 72°C for 35 S, with a 
final extension at 72°C for 10 min. An aliquot of all PCR products was run on a 1.5% (w/v) agarose 
gels with a 100 bp DNA ladder (Fermentas-Russia) and electrophoresed at 75 V for 40 min. The 
bands were visualized using ethidium bromide staining and photographed after UV treatment by a 
transilluminator (UV doc, England). 
 
Data analysis 
Chi square test was used to determine whether there was any significant difference between 
the frequency of VZV in the patients with multiple sclerosis and the control group and their 
demographic characteristics and relationship with each other (SPSS software 17). 
 
Results  
In this study, 183 blood samples were examined while 83 samples belonged to the patient 
group and 100 samples belonged to the control group. Blood samples from the patient group were 
collected based on factors such as age, gender, geographical areas, a history of viral infection, 
genetic, medicines and disease duration. The control group samples were collected adjusting the 
patient group. To describe the samples features, first the collected data were summarized and 
concluded by descriptive statistics index, then all the results from observing the selected samples 
were generalized to the society. 
The patients who suffered from MS based on age group were: 21 individuals (25.3%) under 
30 years old, 55 individuals (66.27%) 30 to 50 years old, 7 individuals (8.43%) 30 to 50 years old, 
and subsequently the control group were: 31 individuals under 30 years old, 63 individuals 50 to 70 
years old, 6 individuals 50 to 70 years old. Based on gender, from the patient group there were 24 
men (28.92%), 59 women (71.08%) and from the control group: 30 men, 70 women. Based on a 
family history of MS and a history of viral infection in the patient group were: 12 individuals 
(14.45%) with family history of MS and 30 individuals (36.14%) with viral infection. The PCR 
technique was used to identify the DNA of virus the amplified fragments of human beta-globin gene 
and Viral DNA were 122 bp and 267 bp, respectively (Figure 1). 
Briefly, the frequency distribution of VZV virus based on age group of MS patients 
included: 4 individuals (19.05%) under 30 years old, 1ه4 individuals (25.45%) 30 to 50 years old, 3 
individuals (86.42%) 50 to 70 years old,; and the control group were: 3 individuals (68.9%) under 
30 years old and 6 individuals (52.9%) 30 to 50 years were infected with the virus. The frequency 
distribution of VZV based on gender from the patient group ,4 men (16.67%) and 17 women 
(28.81%),and from the control group, 3 men (10 %)and 6 women (57.8%) were infected with the 
virus. 3 individuals (25%) based on family history of MS and 10 individuals (33%) based on history 
of viral infection were infected with the virus from the patient group (table 1&2). 
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Figure 1. VZV amplification products analyses in a 1.5% agarose gel stained with ethidium 
bromide. Lane M: molecular marker 100bp, lane 1 viral DNA, lane 2 human beta-globin gene 
and lane 3 negative control 
 
Table 1. Relative and absolute frequency of VZV infection in patients with MS 
Index Number +VZV -VZV p-value 
Age 
>30 21 4 17 
0.455 30-50 55 14 41 
50-70 7 3 4 
Gender Male 24 4 20 0.282 Female 59 17 42 
Family history of MS ü 12 3 9 0.374 û 71 18 53 
History of viral infection ü 30 10 20 0.293 û 53 11 42 
 
Table 2. Relative and absolute frequency of VZV infection in the control group 
Index Number +VZV -VZV p-value 
Age 
>30 31 3 28 
0.729 30-50 63 6 57 
50-70 6 0 6 
Gender Male 30 3 27 0.453 Female 70 6 64 
 
Virtually, the frequency distribution of VZV virus in the patient and control groups was: 21 
individuals (25%) from patients and 9 individuals (9%) from controls were viral infected. P-Value 
was reported (0./004), which showed there was a significant relationship between the frequency of 
VZV virus and the MS patient group. 
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Discussion 
The exact cause of MS is still unknown (Baraun et al., 2005). MS is a multifactorial disease 
which means more than one factor needs to interact each other and cause the disease (Ramagoplan 
et al., 2007). There is a main probable that viruses may stimulate the immune system and cause MS 
in people who are genetically susceptible to MS (Shaygannejad and Sadrameli., 2009). 
 For nearly a decade, studies have confirmed that viral infections play an important role for 
developing MS (Kurtzke et al., 1993; Larner, 1986). Then, a wide list of viruses related to MS  has 
been offered. Many clinical studies have suggested that viral or bacterial infections can be one of the 
causes of MS (Gilden., 2005; Buljevac et al., 2002). In these studies the role of some viruses such as 
EBV, HSV, CMV in MS patients were examined (Sandgol et al., 2011; Djelilovic and Alajbegovic., 
2012; Wandinger et al., 2000). The findings of researchers have represented a significant prevalence 
of these viruses in  patients with MS. Although the investigation of the noted viruses has not been 
the purpose of this study, the results have showed that the viral infections have an important role in 
causing MS. Since there are a few studies about the role  of VZV virus in causing  MS, the present 
study has investigated the prevalence of VZV virus in MS patients and compared it with the control 
group by PCR technique. The other purpose of this study has been the comparison of the VZV 
prevalence between the MS patients and control group based on age, gender and epidemiological 
factors. The findings have showed there is a significant relationship in MS patients compared with 
the control group. Similar to this research, some researchers such as Ordonez and his colleague in 
2004 and 2010 (Ordonez et al., 2010; Ordonez et al .,2004) could find out a significant relationship 
between VZV and MS. But, there are some researchers such as Franciotta and his colleague in 1996 
and 2009 (Franciotta et al., 2009) reported lack of a significant relationship between VZV and MS 
just unlike the present research. Currently, we have been characterizing the genomic profile of VZV 
found in the blood of MS patients.  
 
Conclusion 
Considering the prevalence of ediopathological disease in different areas in the world and in 
Iran, among young adults, and also the stable effect of this disease on life style of patients, and 
according to the available evidence and hypothesis about the relationship of infection with MS , it is 
necessary to perform foundational studies based on etiology by the view of the probable role of 
viruses. Thus, this study has investigated the prevalence of VZV virus in blood samples of MS 
patients and control group. The results have represented a significant relationship between VZV and 
MS. Further studies are still required to figure out the relationship between viral infections in 
causing MS.  
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